Do current therapeutic anti-A beta antibodies for Alzheimer's disease engage the target?
Andrew D Watt, Gabriela AN Crespi, Russell A Down, David B Ascher, Adam Gunn, Keyla A Perez, Catriona A McLean, Victor L Villemagne, Michael W Parker, Kevin J Barnham, Luke A Miles
Acta Neuropathologica | SPRINGER | Published : 2014
This work was funded by the National Health and Medical Research Council of Australia (NHMRC) and we thank the AIBL Flagship Study of Aging for the provision of blood samples. Funding was also received from the Victorian Government Operational Infrastructure Support Scheme to St Vincent's Institute. D.B.A was supported by a Victoria Fellowship from the Victorian Government and a Leslie (Les) J. Fleming Churchill Fellowship from The Winston Churchill Memorial Trust. M. W. P. is an NHMRC Research Fellow.